INS and hyperandrogenism: Given the additive reproductive, metabolic, and cardiovascular risks with the co-existence of PCOS and obesity, the first-line intervention in these patients is weight loss and lifestyle modifications with the goal of losing at least 5% of body weight, which has been associated with improved ovulation, hyperandrogenism, and insulin sensitization [6,9].